In this study, we tested the hypothesis that fasudil, a Rho kinase inhibitor, would protect against contrast-induced acute kidney injury (CI-AKI) in a mouse model and attempted to elucidate the mechanism involved. Mice subjected to unilateral ligation of the left anterior renal pedicle were divided into four groups: (1) control group, (2) CI-AKI induced by contrast media (CM group), (3) CI-AKI plus low-dose fasudil (LD group) and (4) CI-AKI plus high-dose fasudil (HD group). Animals from groups 2-4 received iodixanol (4.0 g iodine/kg), and the control group received saline. At 12, 2 hr before iodixanol injection and 4 hr after iodixanol administration, the animals in groups 3-4 received 3 or 10 mg/kg fasudil, respectively. Renal blood flow, renal function parameters, kidney histology and the expression of proteins that regulates apoptosis and inflammation were determined 24 hr later. Fasudil treatment notably ameliorated contrast medium-induced medullary damage, restored renal function, suppressed renal tubular apoptosis, ameliorated redox imbalance and DNA damage. Fasudil had a nephroprotective effect that was partially attributed to its anti-inflammatory, anti-apoptotic and antioxidant effects of inhibiting the Rho/ROCK pathway.
The implications of the use of radiographic contrast agents have increased remarkably following the development and popularization of cardiac diagnostic and therapeutic interventions. The use of radiographic contrast agents resulted in an increasing incidence and mortality of contrast-induced acute kidney injury (CI-AKI). CI-AKI has been reported to be the third-most common cause of acute renal failure in hospitalized patients [1, 2] . The mechanisms responsible for renal damage in this disease and effective therapeutic strategies to preserve the kidney are being intensively studied [3] [4] [5] .
Rho kinase is a protein kinase that is involved in the Rho/ ROCK signalling pathway, that phosphorylates downstream targets, including myosin light-chain and myosin light-chain phosphatase (MYPT-1), and that modulates actin cytoskeletal organization and endothelial barrier function [6] . ROCK also participates in cell adhesion, migration, proliferation, cytokine activation, inflammatory cell migration, smooth muscle cell contraction and cell cycle regulation. Several recent studies suggest [7, 8] that the inhibition of the Rho/ROCK pathway can produce various effects, including anti-inflammatory, antiapoptosis and antioxidant effects, as well as vascular dilation and improvements in endothelial function. It has recently been shown [9] that statins can protect diabetic rats from contrast medium-induced renal tubular cell apoptosis by suppressing the Rho kinase pathway. The protective effects of ROCK inhibitors have been reported in a variety of renal injury models [10] [11] [12] [13] . This study aimed to examine the protective effects of fasudil, a ROCK inhibitor, in CM-induced nephropathy.
Materials and Methods
Animals. Six-to eight-week-old male BALB/c mice weighing 25-30 g were housed in a SPF-grade laboratory animal room and maintained on a 12-hr light/dark schedule at a temperature of 20°C; the mice were allowed free access to food and water. This study was performed in strict accordance with the guidelines of the Institute for Laboratory Animal Research of Nanjing Medical University. The protocol was approved by the Committee on the Ethics of Animal Experiments of Nanjing Medical University.
Mouse model of CI-AKI. The CI-AKI model was performed as described previously with minor modifications [14] . Mice were anaesthetized with 3% pentobarbital sodium (40 mg/kg) and were subjected to unilateral ligation of the left anterior renal pedicle, including the renal artery, renal vein and ureter. Those mice were divided into four groups (n = 10 per group): control, CM (contrast media), LD (low dose of fasudil) or HD (high dose of fasudil). Seven days after the surgical operation, the animals from the CM, LD and HD groups received the contrast medium (4 g of iodine/kg iodixanol through the tail vein), whereas the control group received the same volume of saline. Twenty-four hours before contrast administration, animals had restricted access to water. Fasudil or saline was injection i.p at three time-points: 12 hr before contrast administration, 2 hr before contrast administration and 4 hr after contrast administration. The animals in the LD and HD groups received fasudil (3 or 10 mg/kg) [15] , whereas the control group received the same volume of saline. Twenty-four hours after the iodixanol injection, the animals were anaesthetized with 3% pentobarbital sodium (40 mg/kg). Renal blood flow was evaluated, and subsequently, blood and urine samples were collected. The animals were killed by cervical dislocation, and kidneys were obtained for further examination.
Preparation of renal sections. After drawing of blood samples, kidney was perfused with ice-cold Krebs buffer for 30 sec. Subsequently, samples of renal cells were collected for flow cytometry Author for correspondence: Dingguo Zhang, Department of cardiology, the first affiliated hospital of Nanjing medical university, Nanjing 210029, China (e-mail zhdg0223@126.com).
analysis immediately or preserved in liquid nitrogen for Western blot or fixed in a periodate-lysine-paraformaldehyde (PLP) solution for histochemistry or immunohistochemistry (n = 5, each group). The tissues were dehydrated in an ascending gradient series of ethyl alcohol, cleared in xylene and mounted in molten paraplast at 58-62°C. Sections of 4 lm thickness were cut for examination by light microscopy, as previously described [16] [17] [18] .
Colour doppler flow imaging of kidneys. Animals were depilated in the abdominal region. A high-frequency ultrasound imaging system for small animal research (Vevo 2100; Visualsonics, Toronto, Canada) equipped with an MS-400 transducer with a 24-MHz central frequency was used to measure the diameters (RAD) and velocity time integrals (VTI) of the right renal arteries, as well as the heart rates (HR). The right renal blood flow (RRBF) can be estimated using the following formula: RRBF = 1/4 9 p 9 RAD 2 9 VTI 9 HR.
Flow cytometry analysis. Renal cells were incubated with 5 mM diacetyldichlorofluorescein (DCFDA) (Invitrogen, Waltham, MA, USA) and were placed in a shaker at 37°C for 30 min., followed immediately by flow cytometry analysis using a FACSCalibur flow cytometer (Becton Dickinson, Heidelberg, Germany) and/or a fluorescence microscope to analyse the intracellular ROS levels [19] .
Biochemical measurements.
Serum urea nitrogen (BUN) and serum creatinine (Cr) levels. Serum BUN level was detected according to the manufacturer's instructions (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). Serum Cr was determined using enzymatic methods (Nanjing Senbeijia Bioengineering Institute, Nanjing, China).
Urinary N-acetyl-beta-D-glucosaminidase (NAG). For the experiment to assess renal tubular injury, urine samples were collected and the NAG activity in urine was determined using a b-N-acetyl-glucosaminidase assay kit (Nanjing Jiancheng Bioengineering Institute).
Levels of TNF-a and IL-6 in serum and renal tissue. Levels of the TNF-a and IL-6 proteins in the conditioned media were measured using an enzyme-linked immunosorbent assay (ELISA) (Nanjing SenBeiJia Biological Technology Co., Ltd., Nanjing, China), according to the manufacturer's protocol.
Histochemical or immunohistochemical staining.
Periodic acid-Schiff (PAS) staining. For the histopathological analysis, the samples were cut into 4-lm-thick sections, stained with PAS stain and were then examined and evaluated microscopically. The PAS-stained tissue sections were viewed under light microscopy, and 10 microscope fields per section were examined at 4009 magnification. Acute renal injury was scored semi-quantitatively using tubular degeneration score (TD) as previously described [20] .
Immunohistochemical staining. Immunohistochemical staining was performed using previously described methods [16] [17] [18] . Primary antibody incubations were followed by a 1-hr incubation with an HRP-conjugated secondary antibody. The immunoreactive bands were visualized using enhanced chemiluminescence reagent and exposed to Hyperfilm-ECL. The intensity of the bands was measured using ImageJ software version 1.29.
Statistical analysis. All analyses were performed using SPSS software (version 16.0; SPSS Inc., Chicago, IL, USA). The measured data are described as the means AE S.E. and were analysed by Student's t-test and one-way ANOVA to compare the differences between groups. p < 0.05 was considered statistically significant.
Results
Fasudil ameliorates the impaired renal function induced by iodixanol.
As shown in fig. 1 , the mice showed marked increases in the serum Cr, serum BUN and urinary NAG levels following iodixanol administration compared with those of the control animals (all p < 0.05). The inhibition of Rho kinase activity by highdose fasudil resulted in significantly improved renal function, with significantly reduced serum Cr and serum BUN levels compared with those of the CM group (p < 0.05). However, the low-dose treatment had no significant effects. Fasudil can substantially decrease the urinary NAG levels, regardless of the dose, compared with that of the CM group (both p < 0.05).
Fasudil ameliorates iodixanol-induced nephrotoxicity.
As shown in fig. 2 (upper panel), PAS staining revealed that the CM-treated mice developed moderate tubular injury with tubular degeneration 24 hr after the administration of iodixanol, including the loss of brush border membranes, the formation of a cast, the vacuolization of tubular epithelial cells and the dilation of tubules. However, when treated with highdose fasudil, the damage at 24 hr was limited to the mild swelling of the tubules, and less histological damage was visible; however, the low-dose treatment showed weak curative effects. Semi-quantitative injury scoring in the CM group showed a significant increase in the TD scores compared with those of the control group ( fig. 2 , lower panel), thus reflecting significant kidney injury. The TD scores in the high-dose fasudil group were significantly less than the scores in the CM and LD groups (p < 0.05), while the lower dose had no effect.
Fasudil reverses the iodixanol-induced reduction of RABF.
As shown in fig. 3 , we detected RABF using colour Doppler flow imaging. The administration of iodixanol substantially reduced RABF compared to the control group (p < 0.05). However, the animals displayed increases in RABF and renal vasodilation in response to the high-dose fasudil treatment compared with the CM group (p < 0.05), while the lower dose had no effect. Our study indicated that fasudil can ameliorate the renal haemodynamic disorder after contrast media injection.
Fasudil decreases iodixanol-induced Rho kinase activation.
We first detected the expression of the Rho kinase proteins, including Rho kinase 1 (ROCK-1) and Rho kinase 2 (ROCK-2), to examine the effect of Rho kinase on iodixanolinduced renal injury. As shown in fig. 4 , there was no significant difference in the ROCK-1 protein levels among the four groups. However, Rho kinase 2 activity was significantly increased 24 hr after iodixanol application. High-dose fasudil can substantially reduce the levels of the ROCK-2 protein compared with those of the CM group, while the lower dose had no effect. MYPT-1 is a Rho kinase-specific effector; MYPT-1 phosphorylation has been used to evaluate ROCK activity in the kidney. We detected endogenous levels of the Thr853-phosphorylated form of the MYPT1 protein. There was no significant difference in the MYPT-1 protein levels among the four groups. In agreement with our Rho activity data, MYPT-1 phosphorylation and the ratio of p-MYPT1/MYPT1 were markedly increased in the kidneys of the CM-treated mice compared with those of the controls. In comparison, treatment with high-dose fasudil significantly reduced the increase in phosphorylated MYPT-1 and the ratio of p-MYPT1/MYPT1 in mice (p < 0.01), while the lower dose had no effect.
Fasudil prevents iodixanol-induced renal cell apoptosis. The expression of pro-and anti-apoptotic markers was determined, and the TUNEL assay was performed. As shown in fig. 5A , the number of TUNEL-positive cells and the levels of caspase-3 and cleaved caspase-3 were increased in the iodixanol-treated kidneys, whereas few apoptotic cells were observed in the control group. High-dose fasudil substantially decreased the number of apoptotic cells compared with those of the CM group ( fig. 5C ), while the lower dose had no effect.
The levels of caspase-3 and Bax were significantly increased in the CM group compared with the control group (p < 0.01, fig. 5B ). The high-dose fasudil treatment significantly attenuated the expression of these pro-apoptotic markers compared with that of the CM group (p < 0.01). Although the low-dose fasudil treatment tended to decrease the levels of these pro-apoptotic markers, the difference was not significant compared with those of the CM group ( fig. 5D ). We also found that contrast media did not affect the expression of bcl-2, an anti-apoptotic protein, compared with that of the control group. However, the high-dose fasudil treatment obviously increased the bcl-2 levels compared with those of the CM group, while the lower dose had no effect. The total Akt protein levels were not significantly different among the four groups. The p-Akt/total Akt ratio was significantly reduced in the CM group compared with that of the control group (p < 0.05). However, the high-dose fasudil treatment obviously increased the p-Akt/total Akt ratio compared with that of the CM group ( fig. 5E ), while the lower dose had no effect.
Fasudil reduces the iodixanol-induced increases in the phospho-NF-KB p65 levels and inflammation. The NF-KB signalling pathway is a type of pro-inflammatory pathway; it regulates a large number of inflammatory cytokines, including TNF-a, IL-6 and iNOS. Phospho-NF-KB p65 has been reported to be a marker of NF-KB pathway activation. We analysed the expression of phospho-NF-KB p65 in the kidneys using Western blot analyses. As shown in fig. 6A , the level of phospho-NF-KB p65 significantly increased after iodixanol injection compared with that of the control group (p < 0.01). However, the level of phospho-NF-KB p65 significantly decreased in the fasudil-treated mice, regardless of the dose, compared with that of the contrast media-treated mice.
Then, we investigated the expression of TNF-a, IL-6 and iNOS in tubules and serum. As shown in fig. 6B -F, the levels of TNF-a and IL-6 in both serum and renal tissue homogenate and the staining of these inflammatory cytokines in tubules were significantly up-regulated after iodixanol injection compared to those of the control group (p < 0.05). Fasudil can substantially reduce the serum IL-6 and TNF-a levels ( fig. 6B,C) . Additionally, fasudil decreased the expression of TNF-a and IL-6 in the kidney ( fig. 6D-F) , regardless of the drug dose, compared with that of the CM group (p < 0.05). However, only the high-dose fasudil treatment could significantly down-regulate the number of iNOS-positive cells compared with that of the CM group ( fig. 6F) . Overall, fasudil decreased the phospho-NF-KB p65 levels and inhibited the expression of inflammatory cytokines in the kidneys.
Fasudil ameliorates the iodixanol-induced redox imbalance and DNA damage mediated by oxidative stress. It was observed through flow cytometry analysis that the intracellular ROS levels were dramatically increased in the renal tubular epithelial cells from the CM group of mice compared with those of the control group (p < 0.05, fig. 7A,B) . Fasudil significantly and dose dependently decreased the intracellular ROS levels compared with those of the CM group ( fig. 7B , p < 0.05). The compound 8-OHdG is a specific biomarker of DNA damage induced by oxidative stress. As shown in fig. 7C , the percentages of 8-OHdG-positive cells in kidneys of the iodixanol-treated mice were significantly increased compared with the control group. Fasudil can substantially decrease the expression of 8-OHdG in a dose-dependent manner ( fig. 7E ). Then, we detected SOD activity, including SOD-1 and SOD-2 activities ( fig. 7D ). As shown in fig. 7F , mice treated with a high dose of fasudil showed higher expression of the SOD-1 protein in the kidneys than the CM group of mice. The low-dose fasudil treatment tended to increase the levels of the SOD-1 protein, but the difference was not significant compared with those of the CM group ( fig. 7F ). However, no differences in the levels of the SOD-2 protein were detected among the four groups ( fig. 7G ).
Discussion
In this study, the CM-treated mice exhibited renal dysfunction, increased renal oxidative stress and inflammation, tubulointerstitial fibrosis, and impaired renal structure compared with the control animals. This study firstly establishes a role for Rho kinases in CM-mediated kidney injury in mice and shows that CM-induced nephritis could be prevented and treated by inhibiting Rho kinases. The major findings are summarized as follows: (1) fasudil treatment protected mice from substantial impairments in renal function and structure in the CM-induced kidney injury model; (2) fasudil suppressed renal oxidative stress and inflammation, improved renal antioxidant defence capacity and modulated the expression of PI-3K/AKT in the kidney, thus inhibiting cellular apoptosis and intracellular vacuolization; and (3) fasudil attenuated the levels of phospho-NF-KB p65 and the subsequent inflammatory cytokine release. Currently, the prevalence of CI-AKI increases as the number of imaging and interventional procedures using contrast media that are performed increases, particularly in older and comorbid patients [21, 22] . CI-AKI is associated with increased costs of medical care and long-term admissions and is a strong predictor of poor early outcome and late outcome, particularly in patients who are in need of dialysis. Establishing the proper animal models of CI-AKI is important to help us understand the mechanisms involved and prevent the disorder. However, significant resistance to contrast-induced nephrotoxicity in healthy animals is observed [23] . Simple intensification of a single insult of contrast medium does not lead to reliable models. Therefore, pre-treating animals with additional insults is essential to establish a reliable and reproducible mouse model of CI-AKI. The incidence of CIN dramatically increases in patients with pre-existing renal impairments [24] . Significant alterations in renal function parameters have been observed after unilateral ligation of the renal vein [25] . At the same time, a more marked increase in plasma creatinine levels has been observed in rats with a unilateral ureteral obstruction [26] . And, unilateral occlusion of the renal artery could also induce renal dysfunction [27] . Furthermore, that concomitant volume depletion, which frequently occurs in the setting of experimental AKI, can induce a pre-renal state, such that the increases in the BUN and Cr levels overestimate the severity of renal damage [28] . Consistent with these data, in our study, urinary NAG activity, a more sensitive marker of renal tubular injury, was significantly elevated in mice with unilateral renal occlusion 24 hr after iodixanol injection. Moreover, as expected, the induction of CIN induces a significant increase in serum Cr and BUN levels. We believe that the complete unilateral occlusion of the renal artery, vein and ureter, plus the effect of hydrate to mice, following the administration of contrast media, might together contribute to this marked change in the renal functional parameters. A previous study [29] has shown that the administration of contrast medium to rats significantly increased serum Cr levels, whereas only minor changes in histology scores were observed. In our model, the histopathological examination of the kidneys from the animals in the experimental group showed more serious injuries than the control group, indicating that the technique induced AKI in the tested model.
To prevent CI-AKI, many therapeutic strategies aimed at different pathological mechanisms have been implemented; however, the role of different strategies is still controversial. Therapeutic modalities mainly include risk factor modification, hydration, vasodilators, tubular alkalization, diuresis, antiinflammatory and antioxidant agents, and adjustment of Fig. 7 . Effects of fasudil on oxidative stress and renal DNA damage. ROS levels in the kidneys from the CM group of mice were increased compared with the control group, as determined by flow cytometry. The percentage of 8-hydroxydeoxyguanosine (8-OHdG)-positive cells was increased in the CM group. Fasudil treatment remarkably decreased the ROS levels and percentages of 8-OHdG-positive cells and increased the levels of the antioxidative enzyme SOD-1, but had no effect on SOD-2. (A, B) ROS levels in the kidneys from the four groups were detected by flow cytometry. (C, E) Representative micrographs of paraffin-embedded kidney sections from four groups of mice that were immunohistochemically labelled for 8-OHdG (4009). The positive cell percentages of 8-OHdG relative to the total number of cells were measured. (D, F, G) Western blots of kidney extracts to analyse SOD-1 and SOD-2 expressions. The SOD-1 and SOD-2 protein levels were assessed by densitometric analysis and normalized to the b-actin protein levels. The values are presented as the mean AE S.E. *p < 0.05,**p < 0.01,***p < 0.001 versus the control group. contrast medium volume and osmolality. Emerging evidence has shown that fasudil, a specific inhibitor of Rho kinase, has multiple beneficial effects in drug-induced kidney disease, including cisplatin-induced AKI, rhabdomyolysis-induced AKI and cyclosporine-induced kidney injury [11, 30, 31] . However, the renoprotective effect of fasudil and its molecular mechanisms in CM-AKI remain to be determined. ROCK belongs to the AGC [protein kinase A (PKA)/protein kinase G/protein kinase C (PKC)] family of serine/threonine kinases, which is a key downstream effector of the small GTPase, Ras homologue gene family, member A (RhoA) [32, 33] . There are two ROCK isoforms, namely ROCK-1 (also referred to as ROKa or p160ROCK) and ROCK-2 (also referred to as ROKb or Rho kinase); however, isoform-specific regulation remains largely unknown. Although both Rho kinases appear to have different activities at the cellular level, disruption of the genes for the two isoforms in mice resulted in similar phenotypes, suggesting functional redundancy between the two isoforms. Rho kinase 1 deletion reduced chemotactic leucocyte migration into inflamed tissue [34] . However, Rho kinase 2, but not 1, was described to play a dominant role in the regulation of inflammation and fibrosis in the kidney [35] . In accordance with these findings, only Rho kinase 2 activity was up-regulated in our mice after the CM treatment, suggesting a predominant role for Rho kinase 2 in inflammatory signalling. The lowdose fasudil treatment insufficiently inhibited ROCK-2 expression. In accordance with those findings, we found that only the high dose, but not low-dose fasudil treatment, could significantly protect mice from impairments in renal function and structure in the CM-induced kidney injury model. Blood flow to the kidney is normally kept within relatively strict limits due to autoregulation [36] , and the adequate renal function is a result of a generous renal blood flow. RABF can be unevenly distributed and shunted from superficial to deeper cortical vessels in normal physiological condition and may be heterogeneous in various pathological conditions. In our present study using Colour Doppler flow imaging, RABF decreased significantly in CM group, whereas the RABF increased after fasudil treatment. This result may suggest that the administration of fasudil improves the RABF after the CM injection, which is coincident with the reports that fasudil causes vasodilation in vascular beds and increases renal blood flow [37, 38] . And there were significant differences between the groups in the changes in plasma Cr and BUN levels. In addition, we observed increased levels of phosphorylated MYPT-1, a downstream mediator of ROCK, in the kidneys of the CM-treated mice, indicating the involvement of the elevated activity of the Rho/ROCK 2 pathway in the pathogenesis of CM-induced nephropathy. Therefore, we investigated whether the inhibition of this pathway might be beneficial in ameliorating or treating CM-induced damage.
Renal cell apoptosis is important in the pathogenesis of CI-AKI. A previous study has reported that Rho kinase is an important factor that regulates apoptosis [9] , mainly by inhibiting the PI3K/Akt pathway [39, 40] . In the present study, we used TUNEL staining and immunohistochemical staining of cleaved caspase-3 to reveal the apoptotic cells in the kidneys.
Our study showed that high-dose fasudil treatment can significantly reduce the percentage of TUNEL-positive and cleaved caspase-3-positive cells. The PI3K/Akt pathway is an important cell survival signalling pathway, and as a survival factor, phosphorylated Akt can ameliorate cell apoptosis. In the present study, p-Akt expression was decreased after the CM treatment but was significantly up-regulated after high-dose fasudil treatment, showing that the inhibition of Rho kinase can activate the PI3K/Akt pathway and reduce cell apoptosis. Caspases are critical effectors of apoptosis and are involved in both the mitochondrial (intrinsic) and death receptor (extrinsic)-dependent apoptotic pathways. The extrinsic pathway, which utilizes cell surface death receptors, responds to a highly specialized subset of death signals (e.g., inflammatory signals), such as FasL and TNF-a, which bind to their respective receptors and stimulate recruitment of the adapter proteins that can recruit and activate pro-caspase-8. Activated caspase-8 then directly activates caspase-3. Caspase-8 can also indirectly signal through the intrinsic pathway by activating Bax and Bak to trigger the release of cytochrome c. Cytochrome c can activate caspase-9, which then directly cleaves and activates caspase-3. In contrast, the intrinsic pathway relies on signalling through the mitochondria and the endoplasmic reticulum. Many stress stimuli activate caspases through the activation of the bcl-2 family proteins, Bax and Bak, in mitochondria, leading to the release of cytochrome c. This process is antagonized by anti-apoptotic bcl-2 family proteins, such as bcl-2. We have shown that fasudil treatment, regardless of the dose of drug, significantly reduced the number of TNF-a-positive cells, thereby fundamentally inhibiting the extrinsic apoptotic pathways. At the same time, our study demonstrated that high-dose fasudil can significantly reduce the levels of ROCK-2, the phosphorylation of MYPT-1, caspase-3, Bax and up-regulating apoptosis-antagonizing protein bcl-2 and p-Akt. Therefore, we speculate that fasudil can inhibit the activity of Rho kinase and can then up-regulate p-Akt, which can affect caspase-3 through its down-regulation of the downstream apoptotic factor Bax and its up-regulation of the anti-apoptotic factor bcl-2.
Another important pathogenic feature of CI-AKI is oxidative stress reaction [41] . 8-OHdG has been widely used in many studies as a biomarker to measure oxidative DNA damage [42] . Our result indicated that the number of 8-OHdG-positive cells and the intracellular ROS levels were dramatically increased after iodixanol injection compared with those of the vehicle-treated mice. Several studies have provided evidence showing that ROS activate the Rho/ROCK pathway [43] . A previous study has shown that fasudil could inhibit lipid peroxidation in ischaemia/reperfusion-induced injury and chronic cerebral ischaemia in rats by down-regulating ROS production [8, 9] . Therefore, the present study examined whether fasudil ameliorated iodixanol-induced oxidative stress. Similar to these reports, we found that the number of 8-OHdG-positive cells and the ROS levels were significantly decreased after both high-dose and low-dose fasudil treatments compared with those of the CM treatment. Additionally, we investigated the SOD levels to confirm whether fasudil has the potential to up-regulate the activity of antioxidant enzymes, thus reducing oxidative DNA damage. Our experimental results showed that only the high-dose fasudil treatment obviously increased the level of the SOD-1 protein, but had no effect on SOD-2. These findings suggest that oxidative stress systems play a role in the pathogenesis of CM-induced renal injury and that fasudil could improve the renal antioxidant defence capacity and suppress renal oxidative stress and inflammation. The low-dose fasudil treatment insufficiently enhanced the antioxidant defences and inhibited renal oxidative stress by alleviating inflammation; therefore, it could not improve renal function.
The activation of the NF-KB signalling pathway is the initial stimulus for the inflammatory response to CIN [29] . The phosphorylation of the NF-KB p65 subunit at Ser 536 occurs during IKB-dependent and IKB-independent NF-KB-induced transcriptional activation [44] . In addition, ROCK-2 was described to play a dominant role in the regulation of inflammation in the kidney [35] . We observed that CM increases iNOS expression and the nuclear translocation of the p65 NF-kB subunit. The present study showed that fasudil dose independently and effectively decreased the levels of p-p65 protein.
The expression of many inflammatory cytokines, including TNF-a and IL-6, is probably mediated by the activation of NF-jB. AKI induces an inflammatory response, which also results in the formation of ROS that increase local tissue damage [45] . Clinical studies have shown that IL-6 and TNF-a were associated with CIN risk and poor long-term renal outcome after PCI [46, 47] . Catherine et al. have shown that Rho kinase inhibition attenuates LPS-induced renal failure by inhibiting NF-KB p65 signalling and inflammation [48] . Consistent with these data, the present study showed that the low-dose or high-dose fasudil treatments decreased the levels of p-NF-kB and inflammatory cytokine release. Reduced p65 activation and translocation were responsible for the observed effect of Rho kinase inhibition on NF-KB signalling and were associated with a decrease in the kidney IL-6 and TNF-a levels similar to the control levels. The probable mechanism of this phenomenon is that ROCK-2 activity within the nucleus contributed to the NF-KB transcriptional activity after contrast media injection, and this activity was also impeded by Rho kinase inhibitors. The present study indicated that low-dose or high-dose fasudil treatments decreased the p-NF-kB levels and inflammatory cytokine release, but the low-dose fasudil treatment could not inhibit ROCK-2 or activate the Rho/ROCK pathway. Together, these data indicate that the inhibition of the Rho/ ROCK pathway is not the only mechanism that activates the NF-kB pathway. In addition, the activation of the NF-kB pathway and the subsequent release of inflammatory cytokines play an important, but not completely necessary, role in the development of CI-AKI.
Conclusions
In summary, fasudil exerts renoprotective effects by suppressing inflammation, apoptosis and oxidative stress and by ameliorating haemodynamic disturbances. The underlying mechanisms may include the inhibition of Rho/ROCK, the suppression of NF-KB/ROS and the up-regulation of the PI3K/Akt signalling pathways. Inhibitors of the Rho/ROCK pathway may have significant potential as therapeutic interventions for contrast media-induced nephropathy. However, it has been shown that the in vitro activity of fasudil is not strictly limited to Rho kinase, and other Rho kinase-related protein kinases, such as PKA, PRK2, MSK1 and S6K1, are also inhibited by fasudil, although to a lesser extent [49] . Therefore, whether the possibility of inhibition of other protein kinases, such as PKA, exerted renoprotective effects against CI-AKI needs further study in future.
